Cel
In vitro diagnostics have allowed a great deal of progress in medicine but are limited by two factors: (a) the lack of guidelines in collection, handling, stabilisation and storage of biosamples which limits the reproducibility of subsequent diagnoses, and (b) its scale is restrained to the cellular level. To address this first point, this IP, SPIDIA, built of clinicians, academics, tool and assay developers, aims to develop quality guidelines for molecular in vitro diagnostics and to standardize the pre-analytical workflow in related procedures. Regarding the second point, SPIDIA aims to develop modern pre-analytical tools for diagnostics improving the stabilisation, handling and study of free biomolecules within blood, plasma, serum, tissues and tumours. Recent discoveries have revealed that RNA, DNA or proteins, released from pathological sites, like tumour cells or Alzheimer’s disease (AD) brain lesions, into the blood or as a secondary blood based response to the disease can serve as biomarkers for early and reliable molecular diagnosis of such debilitating diseases. Further discoveries have shown that the cellular profiles of these molecules and structures in clinical samples can change during transport and storage thus making clinical assay results and pharmaceutical research unreliable or even impossible. It will therefore be a decisive prerequisite for future and current diagnostic assays to develop standards and new technologies, tools and devices that eliminate the human error in the pre-analytical steps of in vitro diagnostics. At this crucial moment in the development of molecular diagnostics, SPIDIA proposes an IP that reunites 7 private research companies (including 4 SMEs), 1 private research institute, 6 public research organisms, including universities, hospitals and biobanks, one management SME and an official European Standards Organisation. This strong consortium is balanced and empowered to maximise the impacts of in vitro diagnostics on human health.
Dziedzina nauki
Słowa kluczowe
Zaproszenie do składania wniosków
FP7-HEALTH-2007-B
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
CP-IP - Large-scale integrating projectKoordynator
40724 Hilden
Niemcy
Zobacz na mapie
Uczestnicy (16)
8010 Graz
Zobacz na mapie
50121 FIRENZE
Zobacz na mapie
412 51 GOTEBORG
Zobacz na mapie
8634 HOMBRECHTIKON
Zobacz na mapie
0663 OSLO
Zobacz na mapie
8200 AARHUS
Zobacz na mapie
2600 GLOSTRUP
Zobacz na mapie
Zakończenie uczestnictwa
69002 LYON
Zobacz na mapie
252 50 Vestec
Zobacz na mapie
1040 Bruxelles / Brussel
Zobacz na mapie
38100 GRENOBLE
Zobacz na mapie
50121 Florence
Zobacz na mapie
3015 GD Rotterdam
Zobacz na mapie
80333 Muenchen
Zobacz na mapie
20133 Milan
Zobacz na mapie
69002 LYON
Zobacz na mapie